查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363953

2023-2030年全球自動免疫分析儀市場

Global Automatic Immunoassay Analyzer Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 200 Pages | 商品交期: 2-3個工作天內

價格

預計在預測期內（2023-2030），全球自動免疫分析儀市場將以 14.8% 的年複合成長率成長。自動免疫分析儀是用於免疫分析測試的醫療設備類型，有助於檢測特定血液樣本中存在的蛋白質分析。由於它們在發布測試方面的優勢和操作的準確性，它們的使用正在不斷成長。用於診斷和檢測微生物感染的免疫測定需求的成長是預計推動免疫測定分析儀市場成長和需求的重要因素之一。

細分市場前景

全球自動免疫分析儀市場按應用和產品細分。根據應用，市場細分為傳染病、內分泌、藥物監測、慢性病和過敏檢測。根據產品，市場細分為免疫螢光、化學發光、酵素連結螢光系統和放射免疫分析。其中，慢性病細分市場預計將佔據相當大的市場佔有率，因為糖尿病、心血管疾病、癌症和傳染病等慢性病的盛行率不斷上升，推動了對免疫分析等診斷工具的需求分析儀。

預計傳染病細分市場將在全球自動免疫分析儀市場中佔據相當大的佔有率

其中，傳染病細分領域預計將在全球自動免疫分析儀市場中佔據相當大的佔有率。此細分市場的成長歸因於傳染患者病率的增加是推動自動免疫分析儀市場成長的傳統關鍵因素之一。及早發現傳染病對於減少身體受到嚴重損害的可能性非常重要。因此，在最短的時間內對肝炎、流感、性傳染病和許多其他感染等感染進行適當和準確的篩檢預計將成為主要的市場成長因素。因此，該公司正在專注於引入新的、先進的自動化解決方案，以實現更好的篩選。例如，2023 年7 月，Beckman Coulter Diagnostics 的新型DxC 500 AU 化學分析儀（一種自動化化學分析儀）獲得FDA 批准，擴大了公司的臨床化學產品範圍，並展示了對體外診斷行業產品創新的持續承諾。 DxC 500 AU 化學分析儀專為中小型實驗室設計，是 Beckman Coulter 最新推出的幾款解決方案之一，旨在最佳化實驗室工作流程並支援關鍵的臨床決策。

區域展望

全球自動免疫分析儀市場根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，由於技術的快速發展和免疫分析測試在各種應用中的使用量的增加，預計亞太地區將在全球市場中佔據顯著佔有率。例如，2023年4月，中國公司Fapon Biotech Inc.宣布了其創新的化學發光一站式解決方案策略。法蓬化學發光一站式解決方案旨在提供全系列化學發光產品和服務，包括不同等級的全自動化學發光分析儀、開放系統平台、試劑開發支援以及大量生產的高品質核心原料。 Fapon Biotech旨在幫助當地體外診斷（IVD）合作夥伴快速擴展其產品組合併簡化其生產流程，並加速其在化學發光免疫分析行業的業務。

北美地區預計全球自動免疫分析儀市場年複合成長率顯著成長

在所有地區中，北美地區預計在預測期內將以相當大的年複合成長率成長。區域成長歸因於老年人口的增加和生活方式的快速變化。相應地，由於醫療產品的容易取得以及先進的技術以及醫療保健中自動化產品的高採用率。例如，2023 年 1 月，Qiagen 推出了 EZ2 Connect MDx IVD 平台，用於診斷實驗室的自動採樣。該公司在該平台可供研究 18 個月後提供廣泛使用。 EZ2 Connect MDx 設備自動化程度高，使實驗室能夠在 30 分鐘內對多達 24 個樣本進行 DNA 和 RNA 的平行純化。該平台在加拿大、美國和其他國家/地區提供，具有歐盟 CE-IVD 體外器械 (IVD) 合規標誌，適用於歐盟和其他接受此指定的國家。

因此，該國在採用自動免疫分析儀生產方面發生了重大轉變。由於醫療設備的趨勢變化和進步，預計將繼續支持該地區市場收入成長的其他關鍵因素。例如，2023 年 7 月，貝克曼庫爾特在北美首次推出了 DxI 9000 Access 免疫分析儀，滿足臨床實驗室對速度、可靠性、重現性、品質和菜單擴展的需求。 DxI 9000 分析儀已顯示出開發日益敏感和臨床相關檢測的能力，使該平台能夠跟上未來的測試要求，因為醫療保健提供者和製藥公司致力於應對更具挑戰性的疾病。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • Abbott Laboratories
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Carolina Liquid Chemistries Corp
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • F. Hoffmann-La Roche AG
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 全球自動免疫分析儀市場（按應用）
    • 傳染性疾病
    • 內分泌科
    • 藥物監測
    • 慢性疾病
    • 過敏測試
  • 全球自動免疫分析儀市場（按產品）
    • 免疫螢光
    • 化學發光
    • 酵素連結螢光系統
    • 放射免疫分析法

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • Aesku Diagnotics
  • Arlington Scientific
  • Becton Dickinson and Company
  • Biokit S.A
  • BioMerieux
  • BioRad Laboratories
  • Inova DX
  • Luminex Corporation
  • Meril Life Sciences
  • Ortho Clinical Diagnostics
  • Perkin Elmer
  • Randox Laboratories
  • Siemens Healthcare
Product Code: OMR2027717

Title: Global Automatic Immunoassay Analyzer Market Size, Share & Trends Analysis Report by Application (Infectious Diseases, Endocrinology, Drug Monitoring, Chronic Diseases, and Allergy Testing), and by Product (Immunofluorescence, Chemiluminescence, Enzyme Linked Fluorescent System, and Radioimmunoassay)Forecast Period (2023-2030).

The global Automatic Immunoassay Analyzer market is anticipated to grow at a CAGR of 14.8% during the forecast period (2023-2030). Automatic Immunoassay analyzers are the type of medical devices that are used for the immunoassay test which helps in the detection of protein analyze present in a specific blood sample. Their usage is growing owing to their benefits in publishing tests and the accurateness of their operations. The rise in demand for immunoassay to diagnose and detect microorganism-based infections is amongst the significant factors expected to fuel the growth and demand of immunoassay analyzers market.

Segmental Outlook

The global Automatic Immunoassay Analyzer market is segmented on the Application and product. Based on the application, the market is sub-segmented into infectious diseases, endocrinology, drug monitoring, chronic diseases, and allergy testing. based on the product, the market is sub-segmented into immunofluorescence, chemiluminescence, enzyme linked fluorescent system, and radioimmunoassay. Among the application, the Chronic Diseases sub-segment is anticipated to hold a considerable share of the market, owing to the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, cancer, and infectious diseases has driven the demand for diagnostic tools like immunoassay analyzers.

The Infectious diseases Sub-Segment is Anticipated to Hold a Considerable Share of the Global Automatic Immunoassay Analyzer Market

Among the application, the infectious diseases sub-segment is expected to hold a considerable share of the global automatic immunoassay analyzer market. The segmental growth is attributed to Increasing prevalence of infectious diseases is one of the crucial factors that is conventional to drive automated immunoassay analyzers market growth. Early detection of infectious diseases is important to reduce the possibility of severe damage to the body. Thus, proper and accurate screening of infections such as Hepatitis, influenza, STDs, and numerous other infections in minimal time is projected to be a major market growth factor. Hence companies are focusing on introducing new and advanced automatic solution for better screening. For an instance, in July 2023, Beckman Coulter Diagnostics, received FDA clearance for its new DxC 500 AU Chemistry Analyzer, an automated chemistry analyzer, expanding the company's clinical chemistry offering and demonstrating ongoing commitment to product innovation in the in vitro diagnostic industry. Designed for small-to-medium-sized laboratories, the DxC 500 AU Chemistry Analyzer is one of several recent Beckman Coulter solutions designed to optimize laboratory workflows and support critical clinical decisions.

Regional Outlook

The global automatic immunoassay analyzer market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing the rapid technological developments and increase in usage of immunoassay testing for various applications. For instance, in April 2023, Chinese firm Fapon Biotech Inc. announced its innovative chemiluminescence one-stop solution strategy. Fapon chemiluminescence one-stop solution is designed to provide a complete range of chemiluminescence products and services, consisting of different levels of fully automatic chemiluminescence analysers with open system platforms, reagent development support, as well as high quality core raw material in bulk production. Fapon Biotech aims to help local in-vitro diagnostic (IVD) partners quickly extend their product portfolio and streamline their production processes, as well as accelerate their business in the chemiluminescence immunoassay industry.

The North America Region is Expected to Grow at a Significant CAGR in the Global Automatic Immunoassay Analyzer Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising in Geriatric Population and Rapid Change in Lifestyle. Correspondingly owing to easy availability of medical products along with advanced technologies and the high adoption rate of the automatic products in healthcare. For an instance, in January 2023, Qiagen has launched the EZ2 Connect MDx IVD platform for automated sampling in diagnostic laboratories. The company is offering the platform for widescale use 18 months after it was made available for research. The EZ2 Connect MDx device has a high degree of automation and enables laboratories to perform parallel purification of DNA and RNA from up to 24 samples in 30 minutes. Available in Canada, the US and other countries, the platform has EU CE-IVD compliance marking for in-vitro devices (IVD) for the European Union and other countries accepting this designation.

Hence, there is considerable shift of the country towards the adoption of the Automatic Immunoassay Analyzer production. Owing to changing trends and advancements in Medical Devices are other key factors expected to continue to support market revenue growth in the region. For an instance, in July 2023, Beckman Coulter, revealed for the first time in North America the DxI 9000 Access Immunoassay Analyzer, addressing clinical laboratory demands for speed, reliability, reproducibility, quality, and menu expansion. The DxI 9000 Analyzer has shown capability to develop increasingly sensitive and clinically relevant assays enabling the platform to keep pace with tomorrow's testing requirements as healthcare providers and pharmaceutical companies take aim at evermore challenging diseases.

Market Players Outlook

The major companies serving the global automatic immunoassay analyzer market include F. Hoffmann-La Roche Ltd., Abbott, BD, Beckman Coulter, Inc., Ortho Clinical Diagnostics, bioMerieux SA, Biokit S.A, The Binding Site Group Ltd., Quidel Corporation, Immunodiagnostic Systems, Merck KGaA, Olympus Corporation, Nova Century Scientific, Inc., Luminex Corporation, DiaSorin S.p.A., Bio-Rad Laboratories, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in February 2023, Agilent Technologies Inc. announced their xCELLigence RTCA HT (real-time cell analysis high-throughput) platform which integrates with the BioTek BioSpa 8 Automated Incubator. Developed in response to market needs, this combination enables a higher level of workflow automation that provides novel functionality for the development of label-free high-throughput potency assays for the immuno-oncology space and high-throughput viral cytopathic effects (CPE) assays for the vaccine market.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global automatic immunoassay analyzer market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Carolina Liquid Chemistries Corp
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. F. Hoffmann-La Roche AG
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Automatic Immunoassay Analyzer Market by Application
    • 4.1.1. Infectious Diseases
    • 4.1.2. Endocrinology
    • 4.1.3. Drug Monitoring
    • 4.1.4. Chronic Diseases
    • 4.1.5. Allergy Testing
  • 4.2. Global Automatic Immunoassay Analyzer Market by Product
    • 4.2.1. Immunofluorescence
    • 4.2.2. Chemiluminescence
    • 4.2.3. Enzyme Linked Fluorescent System
    • 4.2.4. Radioimmunoassay

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Aesku Diagnotics
  • 6.2. Arlington Scientific
  • 6.3. Becton Dickinson and Company
  • 6.4. Biokit S.A
  • 6.5. BioMerieux
  • 6.6. BioRad Laboratories
  • 6.7. Inova DX
  • 6.8. Luminex Corporation
  • 6.9. Meril Life Sciences
  • 6.10. Ortho Clinical Diagnostics
  • 6.11. Perkin Elmer
  • 6.12. Randox Laboratories
  • 6.13. Siemens Healthcare

LIST OF TABLES

  • 1. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 2. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR ENDOCRINOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR DRUG MONITORING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR CHRONIC DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR ALLERGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 8. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN IMMUNOFLUORESCENCE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN CHEMILUMINESCENCE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN ENZYME LINKED FLUORESCENT SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 16. EUROPEAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. EUROPEAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 18. EUROPEAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 19. ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 21. ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 22. REST OF THE WORLD AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. REST OF THE WORLD AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 24. REST OF THE WORLD AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 2. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR INFECTIOUS DISEASES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR ENDOCRINOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR DRUG MONITORING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR CHRONIC DISEASES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR ALLERGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022 VS 2030 (%)
  • 8. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN IMMUNOFLUORESCENCE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN CHEMILUMINESCENCE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN ENZYME LINKED FLUORESCENT SYSTEM MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. US AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. CANADA AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. UK AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. FRANCE AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. GERMANY AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. ITALY AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. SPAIN AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. REST OF EUROPE AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. INDIA AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. CHINA AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. JAPAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. SOUTH KOREA AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)